Research indicates that semaglutide can effectively make non-diabetic individuals who have difficulty losing excess fat through diet and exercise alone, to lose weight
It effectively targets body fat in specific areas, such as the abdomen, thighs, arms, and chin, allowing for precise lipolysis in problem areas
10.1016/j.redox.2013.05.003 Redox Biol
The best results we've seen in literature come from protocols that extend to a year or more, highlighting that this is a long-term commitment
Karanikas (Eli Lilly and Company) for writing and editorial assistance
The study found increased risk in both patients with type 2 diabetes and patients using semaglutide for overweight or obesity, but the authors noted that the study was observational and could not prove that semaglutide directly caused NAION